The role of human adenovirus early region 3 proteins (gp19K, 10.4K, 14.5K, and 14.7K) in a murine pneumonia model

Journal of Virology

Volumn 70, Issue 4, 1996, Pages 2431-2439

  Sparer, Tim E ^a,c   Tripp, Ralph A ^a,d   Dillehay, Dirck L ^a   Hermiston, Terry W ^b   Wold, William S M ^b   Gooding, Linda R ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b School of Medicine   (United States)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN; MUTANT PROTEIN; RECOMBINANT GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; DEPLETION; HISTOPATHOLOGY; HUMAN ADENOVIRUS; IMMUNE RESPONSE; LUNG INFILTRATE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS PNEUMONIA;

EID: 0029871369     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.4.2431-2439.1996     Document Type: Article

References (75)

1. Allan, W., Z. Tabi, A. Cleary, and P. Doherty. 1990 Cellular events in the lymph node and lung of mice with influenza. J. Immunol. 144:3980-3986.
2. Anderson, M., S. Paabo, T. Nilsson, and P. Peterson. 1985. Impaired intra-cellular transport of class I MHC antigens as a possible means for adenovirus to evade immune surveillance. Cell 43:215-222.
3. Bevan, M. J. 1976. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not crossreact in the cytotoxic assay. J. Exp. Med. 143:1283-1288.
4. Bhat, B. M., and W. S. M. Wold. 1987. A small deletion distant from a splice or polyadenylation site dramatically alters pre-mRNA processing in region E3 of adenovirus. J. Virol. 61:3938-3945.
5. Bhat, R. A., and B. Thimmappaya. 1983. Two small RNAs encoded by Epstein-Barr virus can functionally substitute for the virus-associated RNAs in the lytic growth of adenovirus 5. Proc. Natl. Acad. Sci. USA 80:4789-4793.
6. Brady, H. A., A. Scaria, and W. S. M. Wold. 1992. Map of cis-acting sequences that determine alternative pre-mRNA processing in the E3 complex transcription unit of adenovirus. J. Virol. 66:5914-5923.
7. Brady, H. A., and W. S. M. Wold. 1987. Identification of a novel sequence that governs both polyadenylation and alternative splicing in region E3 of adenovirus. Nucleic Acids Res. 15:9397-9416.
8. Buchmeier, N. A., and R. D. Schreiber. 1985. Requirement of endogenous interferon-γ production for resolution of Listeria monocytogenes infection. Proc. Natl. Acad. Sci. USA 82:7404-7408.
9. Burgert, H., and S. Kvist. 1985. An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens. Cell 41:987-997.
10. Buttyan, R., C. A. Olsson, J. Pintar, C. Chang, M. Bandyk, P.-Y. Ng, and I. S. Sawczuk. 1989. Induction of the TRPM-2 gene in cells undergoing programmed death. Mol. Cell. Biol. 9:3473-3481
11. Chang, D. J., G. M. Ringold, and R. A. Heller. 1992. Cell killing and induction of manganous superoxide dismutase by tumor necrosis factor-α is mediated by lipoxygenase metabolite of arachidonic acid. Biochem Biophys. Res. Commun. 188:538-546.
12. Cox, J. H., R. M. Buller, J. R. Bennink, J. W. Yewdell, and G. Karupiah. 1994. Expression of adenovirus E3/19K protein does not alter mouse MHC class I-restricted responses to vaccinia virus. Virology 204:558-562.
13. Crystal, R. G., I. N. G. McElvaney, M. A. Rosenfeld, C.-S. Chu, A. Mastrangeli, J. G. Hay, S. L. Brody, H. A. Jaffe, N. T. Eissa, and C. Danel. 1994. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nat. Genet. 8:42-51
14. Day, D. B., N. A. Zachariades, and L. R. Gooding. 1994. Cytolysis of adenovirus-infected murine fibroblasts by IFN-gamma-primed macrophages is TNF- and contact dependent Cell. Immunol. 157:223-238.
15. Eichelberger, M., W. Allan, M. Zijlstra, R. Jaenisch, and P. Doherty. 1991. Clearance of influenza virus respiratory infection in mice lacking class I major histocompatibility complex-restricted CD8+ T cells. J. Exp Med. 174:875-880.
16. Ford-Hutchinson, A. W., and J. F. Evans. 1986. Leukotriene B. biological properties and regulation of biosynthesis, p. 141-150. In P J Piper (ed.), The leukotrienes: their biological significance. Raven Press, New York
17. Fox, J., C. Hall, and M. Cooney. 1977. The Seattle virus watch. VII Observations of adenovirus infections. Am. J. Epidemiol. 105:362-386
18. Fruh, K., K. Ahn, H. Djaballah, P. Sempe, P. M. van Endert, R. Tampe, P. A. Peterson, and Y. Yang. 1995 A viral inhibitor of peptide transporters for antigen presentation. Nature (London) 375:415-418
19. Gilead, Z., and H. S. Ginsberg. 1966. Comparison of the rates of ultraviolet inactivation of the capacity of type 12 adenovirus to infect cells and to induce T antigen formation. J. Bacteriol. 92:1853-1854.
20. Ginsberg, H., R. Horswood, R. Chanock, and G. Prince. 1990 Role of early genes in pathogenesis of adenovirus pneumonia Proc. Natl. Acad Sci USA 87:6191-6195.
21. Ginsberg, H., L. Moldawer, P. Sehgal, M. Redington, P. Kilian, R. Chanock, and G. Prince. 1991. A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia. Proc. Natl Acad Sci. USA 88:1651-1655.
22. Ginsberg, H. S., B. U. Lundholm, R. L. Horswood, B. Pernis, W. S. M. Wold, R. M. Chanock, and G. A. Prince. 1989. Role of early region 3 (E3) in pathogenesis of adenovirus disease Proc. Natl. Acad. Sci. USA 86:3823-3827.
23. Gooding, L. R. 1977. Specificities of killing by cytotoxic lymphocytes generated in vivo and in vitro to syngeneic SV40 transformed cells. J Immunol. 118:920-927.
24. Gooding, L. R. 1979. Specificities of killing by T lymphocytes generated against syngeneic SV40 transformants: studies employing recombinants within the H-2 complex. J. Immunol. 122:1002-1008.
25. Gooding, L. R. 1992. Virus proteins that counteract host immune defenses. Cell 71:5-7.
26. Gooding, L. R. 1994. Regulation of TNF-mediated cell death and inflammation by human adenoviruses Infect. Agents Dis. 3:106-115.
27. Gooding, L. R., and C. B. Edwards. 1980. H-2 antigen requirements in the in vitro induction of SV40-speciflc cytotoxic T lymphocytes. J. Immunol. 124: 1258-1262.
28. Gooding, L. R., L. W. Elmore, A. E. Tollefson, H. A. Brady, and W. S. M. Wold. 1988 A 14,700 MW protein from the E3 region of adenovirus inhibits cytolysis by tumor necrosis factor. Cell 53:341-346.
29. Gooding, L. R., T. S. Ranheim, A. E. Tollefson, L. Aquino, P. Duerksen-Hughes, T. M. Horton, and W. S. M. Wold. 1991. The 10,400- and 14,500-dalton proteins encoded by region E3 of adenovirus function together to protect many but not all mouse cell lines against lysis by tumor necrosis factor J. Virol. 65:4114-4123.
30. Gooding, L. R., I. O. Sofola, A. E. Tollefson, P. Duerksen-Hughes, and W. S. M. Wold. 1990 The adenovirus E3-14 7K protein is a general inhibitor of tumor necrosis factor-mediated cytolysis. J. Immunol. 145:3080-3086.
31. Green, M., and W. S. M. Wold. 1979 Preparation of human adenoviruses: growth, purification, and transfection assay. Methods Enzymol. 58:425-435.
32. Grunhaus, A., S. Cho, and M. S. Horwitz. 1994. Association of vaccinia virus-expressed adenovirus E3-19K glycoprotein with class I MHC and its effects on virulence in a murine pneumonia model. Virology 200:535-546.
33. Harris, S. L., A. Yee, B. H. Cohen, R. J. Eisenberg, and H. M. Friedman. 1990 Glycoprotein C of herpes simplex virus type 1 prevents complement-mediated cell lysis and virus neutralization. J Infect Dis. 162:331-337.
34. 2 is crucial in the cytotoxic action of tumor necrosis factor. J. Biol. Chem 268:11290-11295.
35. Hermiston, T. W., R. Hellwig, J. C. Hierholzer, and W. S. M. Wold. 1993. Sequence and functional analysis of the human adenovirus type 7 E3-gp19K protein from 17 clinical isolates. Virology 197:593-600.
36. Hill, A., P. Jugovic, I. York, G. Russ, J. Bennink, J. Yewdell, H. Ploegh, and D. Johnson. 1995. Herpes simplex virus turns off the TAP to evade host immunity. Nature (London) 375:411-415.
37. Hou, S., P. Doherty, M. Zijlstra, R. Jaenisch, and J. Katz. 1992. Delayed clearance of Sendai virus in mice lacking class I MHC-restricted CD8+ T cells. J. Immunol. 149:1319-1325.
38. Hou, S., and P. C. Doherty. 1995. Clearance of Sendai virus by CD8+ T cells requires direct targeting to virus-infected epithelium. Eur. J. Immunol. 25: 111-116.
39. Knauer, M. F., K. J. Longmuir, R. S. Yamamoto, T. P. Fitzgerald, and G. A. Granger. 1990. Mechanism of human lymphotoxin and tumor necrosis factor induced destruction of cells in vitro: phospholipase activation and deacylation of specific-membrane phospholipids. J. Cell. Physiol. 142:469-479.
40. Körner, H., and H.-G. Burgert. 1994. Down-regulation of HLA antigens by the adenovirus type 2 E3/19K protein in a T-lymphoma cell line J. Virol. 68:1442-1448.
41. Krajcsi, P., T. Dimitrov, A. E. Tollefson, T. S. Ranheim, T. W. Hermiston, S. B. Vande Pol, S. M. Laster, and W. S. M. Wold. Unpublished data.
42. Krajcsi, P., A. E. Tollefson, C. W. Anderson, A. R. Stewart, C. R. Carlin, and W. S. M. Wold. 1992. The E3-10.4K protein of adenovirus is an integral membrane protein that is partially cleaved between Ala22 and Ala23 and has a Ccyt orientation. Virology 187:131-144.
43. Krajcsi, P., A. E. Tollefson, C. W. Anderson, and W. S. M. Wold. 1992. The adenovirus E3 14.5-kilodalton protein, which is required for down-regulation of the epidermal growth factor receptor and prevention of tumor necrosis factor cytolysis, is an integral membrane protein oriented with its C terminus in the cytoplasm. J. Virol. 66:1665-1673.
44. Mestan, J., M. Brockhaus, H. Kirchner, and H. Jacobsen. 1988. Antiviral activity of tumour necrosis factor. Synergism with interferons and induction of oligo-2′,5′-adenylate synthetase. J. Gen. Virol. 69:3113-3120.
45. Mestan, J., W. Digel, S. Mittnacht, H. Hillen, D. Blohm, A. Moller, H. Jacobsen, and H. Kirchner. 1986. Antiviral effects of recombinant tumour necrosis factor in vitro. Nature (London) 323:816-819.
46. Openshaw, P. J. 1989. Flow cytometric analysis of pulmonary lymphocytes from mice infected with respiratory syncytial virus. Clin Exp. Immunol. 75:324-328.
47. Pacini, D., E. Dubovi, and W. Clyde. 1984. A new animal model for human respiratory tract disease due to adenovirus. J Infect. Dis. 150:92-97.
48. Pinchard, R. N., J. C. Ludwig, and L. M. McMannus. 1992. Platelet activating factor: a fluid phase and cell associated mediator of inflammation, p. 149-176. In J. I. Gallin, I. M. Goldstein, and R. Syndeman (ed.), Inflammation basic principles and clinical correlates, 2nd ed. Raven Press, New York.
49. Prince, G. A., D. D. Porter, A. B. Jenson, R. L. Horswood, R. M. Chanock, and H. S. Ginsberg. 1993. Pathogenesis of adenovirus type 5 pneumonia in cotton rats (Sigmodon hispidus). J. Virol. 67:101-111.
50. 2 - a mediator between proximal and distal effectors of inflammation. Immunol. Today 12:143-146
51. Rawle, F., T. E. Sparer, and L. R. Gooding. Unpublished results.
52. Rawle, F. C., A. E. Tollefson, W. S. M. Wold, and L. R. Gooding. 1989. Mouse anti-adenovirus cytotoxic T lymphocytes. Inhibition of lysis by E3 gp19K but not E3 14.7K. J. Immunol. 143:2031-2037
53. Rock, K. L., S. Gamble, and L. Rothstein. 1990 Presentation of exogenous antigen with class I major histocompatibility complex molecules. Science 249:918-921
54. Rock, K. L., R. Lisa, S. Gamble, and C. Fleischacker. 1993 Characterization of antigen-presenting cells that present exogenous antigens in association with class I MHC molecules. J. Immunol. 150:438-446.
55. Routes, J. M., and J. L. Cook. 1990 Resistance of human cells to the adenovirus E3 effect on class 1 MHC antigen expression. Implications for antiviral immunity J Immunol. 144:2763-2770.
56. Routes, J. M., B. A. Metz, and J. L. Cook. 1993. Endogenous expression of E1A in human cells enhances the effect of adenovirus E3 on class I major histocompatibility complex antigen expression. J. Virol. 67:3176-3181.
57. Smith, G. L. 1994. Virus strategies for evasion of the host response to infection. Trends Microbiol. 2:81-88
58. Spitalny, G. L., and E. A. Havell. 1984. Monoclonal antibody to murine gamma interferon inhibits lymphokine-induced antiviral and macrophage tumoricidal activities. J. Exp. Med. 159:1560-1565.
59. Stewart, A. R., A. E. Tollefson, P. Krajcsi, S.-P. Yei, and W. S. M. Wold. 1995. The adenovirus E3 10.4K and 14.5K proteins, which function to prevent cytolysis by tumor necrosis factor and to down-regulate the epidermal growth factor receptor, are localized in the plasma membrane. J. Virol. 69:172-181.
60. 2 activity, but not with arachidonic acid release per se. Eur. J. Biochem. 195:465-475.
61. Suto, R., and P. K. Srivastava. 1995. A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. Science 269:1585-1588.
62. Tollefson, A. E., P. Krajcsi, T. W. Hermiston, S. K. Saha, and W. S. M. Wold. Unpublished results
63. Tollefson, A. E., P. Krajcsi, M. H. Pursley, L. R. Gooding, and W. S. M. Wold. 1990. A 14,500 MW protein is coded by region E3 of group C human adenoviruses. Virology 175:19-29.
64. Tollefson, A. E., P. Krajcsi, S. Yei, C. R. Carlin, and W. S. M. Wold. 1990. A 10,400-molecular-weight membrane protein is coded by region E3 of adenovirus J Virol. 64:794-801
65. Tollefson, A. E., A. R. Stewart, S. Yei, S. K. Saha, and W. S. M. Wold. 1991. The 10,400- and 14,500-dalton proteins encoded by region E3 of adenovirus form a complex and function together to down-regulate the epidermal growth factor receptor J. Virol. 65:3095-3105.
66. Tollefson, A. E., and W. S. M. Wold. 1988. Identification and gene mapping of a 14,700-molecular-weight protein encoded by region E3 of group C adenoviruses. J. Virol. 62:33-39.
67. Tufariello, J., S. Cho, and M. S. Horwitz. 1994. The adenovirus E3 14.7-kilodalton protein which inhibits cytolysis by tumor necrosis factor increases the virulence of vaccinia virus in a murine pneumonia model J Virol. 68:453-462
68. Tufariello, J. M., S. Cho, and M. S. Horwitz. 1994. Adenovirus E3 14.7-kilodalton protein, an antagonist of tumor necrosis cytolysis, increases the virulence of vaccinia virus in severe combined immunodeficient mice. Proc. Natl. Acad. Sci USA 91:10987-10991.
69. Welsh, M. J., and A. E. Smith. 1994. Cystic fibrosis gene therapy using an adenovirus vector in vivo safety and efficacy in nasal epithelium. Hum. Gene Ther. 5:209-219.
70. Wherry, J. C., R. D. Schreiber, and E. R. Unanue. 1991. Regulation of gamma interferon production by natural killer cells in scid mice: roles of tumor necrosis factor and bacterial stimuli Infect. Immun. 59:1709-1715.
71. Wold, W. S. M., S. Deutscher, N. Takemori, B. Bhat, and S. Magie. 1986. Evidence that AGUAUAUGA and CCAAGAUGA initiate translation in the same mRNA in region E3 of adenovirus. Virology 148:168-180.
72. Wold, W. S. M., T. W. Hermiston, and A. E. Tollefson. 1994. Adenovirus proteins that subvert host defenses. Trends Microbiol. 2:437-443.
73. Wong, G. H. W., and D. V. Goeddel. 1986. Tumour necrosis factors α and β inhibit virus replication and synergize with interferons. Nature (London) 323:819-822.
74. York, I. A., C. Roop, D. W. Andrews, S. R. Riddell, F. L. Graham, and D. C. Johnson. 1994. A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes Cell 77:525-535.
75. Zilli, D., C. Voelkel-Johnson, T. Skinner, and S. M. Laster. 1992 The adenovirus E3 region 14 7 kDa protein, heat and sodium arsenite inhibit the TNF induced release of arachidonic acid. Biochem. Biophys Res Commun. 188:177-183.